Uncategorized - February 16, 2015
New Interest in “Brain” Drugs
A resurgence in research into drugs for psychiatric and neurological conditions could be coming soon, as the demand for treatments for diseases such as Alzheimers, ALS, Parkinson’s and psychiatric disorders continues to rise and increased scientific knowledge is paving the way for more effective drugs. Investors last year contributed $3.3 billion to firms working on drugs for neurological or psychiatric illnesses, more […]